Medscape Conference Coverage, based on selected sessions at the:

American Diabetes Association (ADA) 67th Scientific Sessions

June 22 - 26, 2007; Chicago, Illinois

This activity is not sanctioned by, nor a part of, the American Diabetes Association.

Featured Coverage

Conference News

  • Continuous Blood Glucose Monitoring Shows No Effect on Glucose Control

    An evaluation of 2 continuous blood glucose monitoring devices indicated no difference among those patients who used the machines and those who did not. Medscape Medical News, July 9, 2007
  • Diabetes Mellitus Associated With Increased Intracerebral Hemorrhage Risk

    Black patients younger than 55 years with diabetes mellitus are at a significantly increased risk for intracerebral hemorrhage. Medscape Medical News, July 6, 2007
  • Fructose but Not Glucose Consumption Linked to Atherogenic Lipid Profile

    Limited consumption of fructose-sweetened beverages is recommended. Medscape Medical News, July 5, 2007
  • Potential Weight-Regulating Gene Identified

    Genetic variability in TBX15 has been associated with differences in body weight and waist circumference, especially in women. Medscape Medical News, July 5, 2007
  • Blood Glucose Instead of HbA1c?

    HbA1c levels, used to measure long-term glycemic control, might soon be replaced with average blood glucose levels, a change experts say will add clarity to diabetic patients looking to manage their disease. A study supporting the change showed a close correlation between average glucose and HbA1c levels, say investigators. Heartwire, July 3, 2007
  • Fracture Risk With Avandia

    Not unlike a prizefighter battered and bruised, rosiglitazone continued to take it on the chin this week with an analysis of ADOPT expanding upon the increased risk of fracture among diabetic women taking the controversial TZD. Heartwire, June 29, 2007
  • Nissen Responds to Rosiglitazone Debate at ADA Meeting

    Much in the spotlight in the past month, Dr. Steven Nissen's audience this time, instead of politicians on Capitol Hill, was a house full of physicians and researchers in a hastily added panel discussion. Heartwire, June 28, 2007
  • Hypoglycemia Risks

    Clinicians should not fear intensifying treatment in diabetic patients with inadequately controlled glucose levels because the subsequent risk of developing hypoglycemia is quite low, even among those with hemoglobin A1c levels close to goal, a new study shows. Heartwire, June 25, 2007
  • CVD Risk and Diabetes

    Diabetic patients requiring glucose-reducing treatment, say investigators, have the same cardiovascular risk as patients who have had a myocardial infarction and should be treated with antiplatelet drugs, statins, and possibly an ACE inhibitor or angiotensin receptor blocker. Heartwire, June 25, 2007
  • Project DIRECT

    Although the runaway growth of diabetes in the United States is not about to be stopped anytime soon, one study offers some encouraging news that community-based initiatives can influence health behaviors and alter the rate of progression of disease. Heartwire, June 25, 2007
  • Statins and Fibrates in Diabetes Mellitus

    Australian investigators showed that treatment with statins and fibrates reduced the risk of developing peripheral neuropathy by 35% and 48%, respectively, among type 2 diabetic patients during a five-year follow-up period. Heartwire, June 25, 2007
Disclaimer

The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.

The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the American Diabetes Association. These materials and the related activity are not sanctioned by the American Diabetes Association or the commercial supporter of the conference and do not constitute an official part of that conference.

©  Copyright © 2007 Medscape.